News



June 2016

Michael nominated for ISEH Board of Directors - go to vote!

link

June 2016

Susanne´s Review article published

link

May 2016

Susanne defended her thesis impressively - congrats Dr. Wingert!

April 2016

Colorectal cancer stem cell paper published - congrats Patrizia

link

Feb 2016

MicroRNA project funded by the Carreras Leukemia Foundation

Jan 2016

Wingert et al. - new STEM CELLS paper- congrats Susanne!

link

Dec 2015

SUMMA CUM LAUDE - congrats Dr. Nadine Haetscher!

Dec 2015

Tabea received MD stipend from the Adolf-Gutknecht-Foundation - congrats!

Nov 2015

"Micro-RNA controls HSC self-renewal" published in Nature Communications

link

Nov 2015

Michael published "Inside BLOOD" article

link

Aug 2015

New PhD student position available

link

July 2015

Fabian, Bartosch and Michael published review article on stem cells in ALL

link

June 2015

Rieger group publishes HSC self-renewal story in CELL REPORTS

link

May 2015

Frederic successfully defended his dissertation (PhD) - congrats Dr. Thalheimer!"

April 2015

BLOOD coauthor paper from Bartosch in the lab - congrats!link

March 2015

Bartosch received prestigeous stipend from the Jose Carreras Leukämie-Stiftung and DGHO - congrats!

Feb 2015

Plenary session talk of Michael at the Keystone Symposium "Hematopoiesis"

Jan 2015

Rieger group contributed to a study published in NATURE link



Basic Mechanisms in Stem Cell Biology

Stem cells raise enormous hope and expectations for regenerative medicine. Since decades hematopoietic stem cell transplantation has become routine treatment for many blood disorders and cancer and is a prime example for successfully applied regenerative medicine. However, many fundamental questions must be addressed for improved therapeutic options in the future.

We focus our research on basic mechanisms that control stem cell fate decisions (self-renewal vs. differentiation, lineage choice, quiescence vs. proliferation). These fate decisions need to be strictly balanced for normal tissue regeneration and for emergency situations, and are dysregulated in diseases (e.g. cancer). We utilize various organ stem cell systems (hematopoietic cells, mammary gland, colon) from mice and humans to unravel molecular and functional clues how these decisions are integrated in normal stem cell biology and how malignant stem cells can be targeted for innovative disease treatment.

Our Mission

We need a detailed knowledge about normal stem cell behavior to create innovative therapies for dysregulated stem-cell driven diseases.

Back to Top

portrait Michael Rieger

Prof. Dr. Michael Rieger

Curriculum Vitae

Supported by